Translational Lung Cancer Research 期刊简介
Translational Lung Cancer Research(TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer.
翻译肺癌研究 (TLCR，Transl Lung Cancer Res，打印ISSN 2218-6751; 在线ISSN 2226-4477) 是一家国际同行评审的开放获取期刊，成立于2012年3月。TLCR由PubMed/PubMed Central和化学文摘社 (CAS) 数据库索引。第一年每季度出版一次，自2013年2月以来每两个月出版一次。它提供了有关预防，早期发现，诊断和治疗肺癌的实用最新信息。其感兴趣的特定领域包括但不限于多模式治疗，标志物，成像，肿瘤生物学，病理学，化学预防以及与肺癌相关的技术进步。
|
期刊ISSN
|
2218-6751 |
|
影响指数
|
6.433 |
|
最新CiteScore值
|
4.30 查看CiteScore评价数据 |
|
最新自引率
|
12.40% |
|
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
|
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址：https://www.deeredit.com/?type=ss2，资深审稿专家为您评估稿件质量，提供针对性改进建议，最终可助您极大提升目标期刊录用率 |
|
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
|
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
|
通讯地址
|
Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China. |
|
偏重的研究方向（学科）
|
Medicine-Oncology |
|
出版周期
|
monthly |
|
出版年份
|
2012 |
|
出版国家/地区
|
Hong Kong |
|
是否OA
|
Yes |
|
SCI期刊coverage
|
Science Citation Index Expanded（科学引文索引扩展） |
|
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
|
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)2区
RESPIRATORY SYSTEM(呼吸系统)2区
否
|
|||||
|
最新的影响因子
|
6.433 | |||||
| 最新公布的期刊年发文量 |
|
|||||
| 总被引频次 | 0 | |||||
| 影响因子趋势图 |
近年的影响因子趋势图（整体平稳趋势）
|
|||||
2022年预警名单预测最新
|
最新CiteScore值
|
4.30
|
||||||||||
| 年文章数 | 225 | ||||||||||
|
SJR
|
1.474 | ||||||||||
|
SNIP
|
1.217 | ||||||||||
|
CiteScore排名
|
|
||||||||||
| CiteScore趋势图 |
CiteScore趋势图
|
||||||||||
|
本刊同领域相关期刊
|
|
| 期刊名称 | IF值 |
| INTEGRATIVE CANCER THERAPIES | 3.246 |
| Hormones & Cancer | 3.83 |
| ENDOCRINE-RELATED CANCER | 5.621 |
| Frontiers of Medicine | 4.546 |
| Molecular Medicine Reports | 2.922 |
| Molecular Therapy-Oncolytics | 7.128 |
| American Journal of Translational Research | 4.019 |
| BREAST | 4.336 |
| Breast Care | 2.831 |
|
本刊同分区等级的相关期刊
|
|
| 期刊名称 | IF值 |
| ENDOCRINE-RELATED CANCER | 5.621 |
| Molecular Therapy-Oncolytics | 7.128 |
| GYNECOLOGIC ONCOLOGY | 5.427 |
| ORAL ONCOLOGY | 5.284 |
| MOLECULAR CARCINOGENESIS | 4.736 |
| BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 10.573 |
| STEM CELLS | 6.214 |
| CANCER GENE THERAPY | 5.927 |
| EJSO | 4.38 |
External peer review: 1-3 months
Publication Ahead of Print: within
| 分享者 | 点评内容 |
